News | March 21, 2024
Bristol Myers Squibb completes acquisition of Karuna Therapeutics
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Pharma Solutions operates 10 research and development and/or production sites globally
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
A five-day inspection was concluded successfully with no critical and no major observations raised
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
The first and only oral androgen deprivation therapy treatment for men with advanced prostate cancer
The drug will target specific genetic mutations prevalent in certain types of cancers
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Subscribe To Our Newsletter & Stay Updated
